prenatal diagnosis

(redirected from Prenatal testing)
Also found in: Thesaurus, Medical, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.prenatal diagnosis - any of the diagnostic procedures used to determine whether a fetus has a genetic abnormality
diagnostic procedure, diagnostic technique - a procedure followed in making a medical diagnosis
echography, sonography, ultrasonography, ultrasound - using the reflections of high-frequency sound waves to construct an image of a body organ (a sonogram); commonly used to observe fetal growth or study bodily organs
amnio, amniocentesis - (pregnancy) extraction by centesis of amniotic fluid from a pregnant woman (after the 15th week of pregnancy) to aid in the diagnosis of fetal abnormalities
fetoscopy, foetoscopy - prenatal diagnosis that allows direct observation of a fetus in the uterus and the withdrawal of fetal blood
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations
Pränataldiagnostik
References in periodicals archive ?
Nevertheless, non-invasive prenatal testing has brought a paradigm shift in prenatal genetic diagnosis, which aims to detect fetal aneuploidies such as trisomies 18, 13, 21 through the assessment of cell-free DNA (cfDNA).
"Is it licit to hire a hitman to resolve a problem?" He also denounced decisions to abort based on prenatal testing, saying a human being is "never incompatible with life".
Elucigene's current product portfolio is complementary to Yourgene's existing non-invasive prenatal testing solutions, broadening the offering of the enlarged group as a provider of molecular diagnostic solutions for reproductive health.
Sofiva Genomics, which provides services spanning prenatal testing, neonatal testing, personalized care, as well as screening for cancer and rare genetic diseases, will be setting up a laboratory in the capital of Thailand, according to a press release by the company.
Generally, non-invasive prenatal testing, or NIPT, analyzes cell-free DNA, or cfDNA, circulating in the maternal blood and has rapidly become the standard follow-up procedure for women classified as high risk following traditional prenatal screening.
It was fronted by Sally Phillips, a popular actress and mother of a son with Down syndrome who set out to critique the use of noninvasive prenatal testing (NIPT) for fetal anomaly and, more specifically, to probe the ethical questions surrounding a decision to terminate when Down syndrome is detected.
The non-invasive prenatal testing (NIPT) will be offered to women who have taken up the initial offer of screening and are found to be at a higher risk of the three conditions.
In the first case, described in 2013, a 37-year-old woman underwent noninvasive prenatal testing (NIPT) at 13 weeks of gestation and received a test report of "aneuploidy detected, trisomy 13 and monosomy 18" (7).
Non-invasive prenatal testing or screening (NIPT/NIPS) using cell-free DNA (cfDNA) has been commercially available for over five years.
28 July 2017 - Luxembourg-based bio-analytical testing provider Eurofins Scientific (EUFI.PA) (Paris: ERF), has finalised the acquisition of a stake in Germany based prenatal testing specialists GATC Biotech AG, the company said.